PharmaSource Podcast

May 21 2024 1
PharmaSource Podcast artwork

Welcome to the PharmaSource podcast: the pharma and biopharma podcast that explores the latest trends, challenges, and commercial opportunities shaping the industry. In each episode we'll be speaking with top executives, researchers, policy makers and other experts, who share their perspectives on the essential issues you need to know about. From the latest breakthroughs in drug development and manufacturing, to the impact of healthcare policy on drug pricing, we cover it all. Make sure to subscribe for your regular dose of pharma insight.

RSS feed Share
Copy RSS


Subscribe on Podcast Addict


AI in Pharma Manufacturing: Pragmatic steps to implement data science in GMP manufacturing

May 21 2024 23 mins  
Aizon is on a mission to integrate modern computing into the complex arena of GMP manufacturing processes in life sciences. In the latest episode of the PharmaSource podcast we sat down with Claus Abildgren, Chief Revenue Officer at Aizon, and David O’Gara, Strategic Advisor to Aizon to understand how artificial intelligence can make an impact on manufacturing in the highly-regu

How To Sell Science: Advice for Better CDMO Sales and Marketing with Dr Jeff Kiplinger

May 17 2024 30 mins  
“The biggest challenge for scientists to understand that it’s not just your expertise that people are buying, it’s your ability to connect with their problem.” Dr. Jeff Kiplinger, a former scientific leader at Pfizer, founded, scaled and sold Averica Discovery Services, a Boston-based CRO specializing in early-stage contract research and analytical development. Now best-s

How Pfizer CentreOne unlocks the power of Pfizer experts for CDMO partners

May 14 2024 45 mins  
Pfizer CentreOne is an “altogether different kind of CDMO”. Unlike a pure play contract development and manufacturing partner, they don’t own their own plants and pharmaceutical development centres. Instead their customers can leverage the wealth of expertise and state-of-the-art facilities Pfizer possesses. Ahead of CDMO Live 2024 we sat down with Tom Wilson, VP of Global C

Supplier Data Excellence: How Astellas are supporting procurement with better data strategies

May 10 2024 29 mins  
“Good quality supplier data is the backbone of procurement,” says Lana Radosevic, Global Supplier Lead in Procurement Excellence at Astellas In her role in Procurement Excellence, Lana Radosevic’s primary focus is on improving supplier data quality across all SaaS systems used by Global Procurement and integrating supplier data. In the latest episode of the PharmaSource po

Terumo: The integrated CDMO doubling capacity

May 10 2024 25 mins  
Terumo is a mid to large size-global medical device company based in Japan, with offices in over 160 countries around the world and over 50,000 products and services. The Terumo Pharmaceutical Solutions Division, also known as ‘PSD’, is a leading manufacturer of injectable solutions – including primary container, infusion therapy devices, general drug delivery devices – an

Grand River Aseptic Manufacturing new state-of-the-art facilities for fill-finish biologics capacity

May 06 2024 15 mins  
Grand River Aseptic Manufacturing (GRAM), as the name suggests, is a leading sterile injectable drug manufacturer based in Grand Rapids, Michigan. Following significant investments in state-of-the-art facilities and equipment, GRAM has capacity for fill-finish biologics, small molecules, and vaccines. Ahead of CDMO Live, we had the opportunity to sit down with David Powell, Vice Pr

Project Martini: How Bayer are shaking up their global contract nanufacturing network in 2024

May 05 2024 22 mins  
Bayer Consumer Health heavily relies on contract development and manufacturing, maintaining a network of nearly 200 contract manufacturers that account for approximately half of their global sales. This is set to change with the Project Martini initiative, which aims to significantly “shake up” and consolidate their network of contract manufacturers. Speaking ahead of CDMO Liv

Onyx Scientific: The Small Molecule CDMO Specialising in Process R&D

May 01 2024 21 mins  
Onyx Scientific is a Contract Development and Manufacturing Organization (CDMO) that specializes in process R&D, non-GMP scale-up, and GMP manufacture for clinical trials and commercial applications. With facilities in the UK and US, their dedicated teams in chemistry, solid-state and analytical chemistry guide small molecule Active Pharmaceutical Ingredient (API) products thr

The Art of Contract Negotiations: Building Strong CDMO Partnerships

Apr 28 2024 39 mins  
“Contract negotiations are often perceived as a POWER GAME but in reality, it has to be a collaboration.” says Dr Roxana Timmermans In the latest episode of the PharmaSource podcast, Dr. Timmermans explains why contract negotiations are of critical importance in pharma outsourcing and shares her framework for success. “Proper negotiation, is the foundation of a strong partner

Digital CMC Maturity: Practical Strategies for Digitisation of Biopharma Manufacturing and R&D

Apr 22 2024 47 mins  
While pharmaceutical companies have proven the return on investing in digital at early stages of drug discovery, manufacturing has been slower to embrace digital transformation. To understand how pharma R&D and manufacturing can unlock more business value through adopting digital tools and technologies, we speak to Digital CMC consultant Mark Buswell. Mark is a chemical enginee